A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HCC / hepatocellular carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 45189
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HCC  (>> Co-occurring Abbreviation)
Long Form:   hepatocellular carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs. FC, ROS, WB
2020 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. MPVTT
2020 1H-NMR based metabolic profiles delineate the anticancer effect of vitamin C and oxaliplatin on hepatocellular carcinoma cells. OXA, VC
2020 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. OPLS-DA, OS
2020 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application. LTP, OS, RFS, US-PMWA
2020 A biodegradable multifunctional porous microsphere composed of carrageenan for promoting imageable trans-arterial chemoembolization. BMPMs, DOX, DSA, iTACE, MRI, SPIO, TACE
2020 A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. CCK, CCKRs, CDE, NASH
2020 A comparative study of monoexponential versus biexponential models of diffusion-weighted imaging in differentiating histologic grades of hepatitis B virus-related hepatocellular carcinoma. ADC, HBV
2020 A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis. CIs, FPRP, ORs, SNPs
10  2020 A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in beta-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience. CHB, CHC
11  2020 A magnetic SERS immunosensor for highly sensitive and selective detection of human carboxylesterase 1 in human serum samples. 4-MBA, hCE1, SERS
12  2020 A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. ALBI, CI, OS, PFS, TACE-MWA
13  2020 A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma. CI, circRNA, EpCAM, HDGF, miRNA, PI3K
14  2020 A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade. AFP, DENA, phospho-ASK1
15  2020 A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation. CI, CT-PMWA, CTP, LTP, tAUC
16  2020 A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma. BCLC, ICG, OS, PFS, TACE
17  2020 A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients. miRNAs, ROC
18  2020 A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy. EGD, SBRT
19  2020 A pipeline to create predictive functional networks: application to the tumor progression of hepatocellular carcinoma. ---
20  2020 A positive feedback loop involving the LINC00346/beta-catenin/MYC axis promotes hepatocellular carcinoma development. lncRNAs
21  2020 A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. ALT, AST, ICGR15, PVP
22  2020 A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma. HCAs
23  2020 A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma. MWA
24  2020 A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea. TACE
25  2020 A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients. CNV, TSGs
26  2020 A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. MRI, NAFLD, NASH
27  2020 Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018. aMRI, CI, cMRI
28  2020 Abernethy malformation and hepatocellular carcinoma: a serious consequence of a rare disease. CPSS
29  2020 Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis. HF, NAFLD
30  2020 Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. AUC, CEUS, DL, R-BMode, R-DLCEUS, R-TIC, TACE
31  2020 Acetyl-11-keto-beta-boswellic acid triggers premature senescence via induction of DNA damage accompanied by impairment of DNA repair genes in hepatocellular carcinoma cells in vitro and in vivo. AKBA
32  2020 Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression. AFP, HBx, PA
33  2020 Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1. aHSCs, Ang-1, HVEC
34  2020 Activation of reactive oxygen species-mediated mitogen-activated protein kinases pathway regulates both extrinsic and intrinsic apoptosis induced by arctigenin in Hep G2. ARG, JNK, ROS
35  2020 Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis. CC, eIF4E, mTOR, p-Akt
36  2020 Acute hemoperitoneum after ruptured hepatocellular carcinoma: First Moroccan SCARE-compliant case report and literature review. CT
37  2020 Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4. APHE, APNHE, CEUS, IHCC
38  2020 Advances in delivery vectors for gene therapy in liver cancer. ---
39  2020 Advances in molecular classification and precision oncology in hepatocellular carcinoma. ---
40  2020 Advances in resection and transplantation for hepatocellular carcinoma. ---
41  2020 Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study. OS, RS
42  2020 AGO2 mediates MYC mRNA stability in hepatocellular carcinoma. Ago2, RBPs, RISC
43  2020 Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma. ALBI, BCLC, CI, PS
44  2020 Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. cccDNA, HBsAg, HBV, OBI
45  2020 An NIR-responsive mesoporous silica nanosystem for synergetic photothermal-immunoenhancement therapy of hepatocellular carcinoma. ICG, NIR, PTT
46  2020 Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression. AR, DHT
47  2020 Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling. ---
48  2020 Apoptosis induction and ERK/NF-kappaB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo. ERK, MMP-9, NF-kappaB, p-ERK, VEGF, XIAP
49  2020 Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. AUC, CT, ER, GGT
50  2020 Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study. aHR, HBV, HCV
51  2020 Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. AFP, BCLC, HBsAg, HR, NSAIDs
52  2020 Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors. PLCs
53  2020 Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants. HRs
54  2020 Association of hepatocellular carcinoma risk with polymorphisms in tumour necrosis factor alpha gene in a Chinese Han population. MALDI-TOF MS, TNF-alpha
55  2020 Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. PD-L1, TACE, TIM-3
56  2020 Autophagy in hepatitis B or C virus infection: An incubator and a potential therapeutic target. ---
57  2020 Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma. MS
58  2020 beta-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. beta-OHB, HDACs
59  2020 Bimodal Molecule as NIR-CT Contrast Agent for Hepatoma Specific Imaging. CT, NIR
60  2020 c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma. ---
61  2020 Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis. CsA, MPG, mPTP
62  2020 Cathepsin C Interacts with TNF-alpha/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma. CTSC, MAPK, TNF-alpha
63  2020 CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. GEPIA, TIMER
64  2020 CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy. CCND1, LCSCs
65  2020 Celastrol-loaded galactosylated liposomes effectively inhibit AKT/c-Met-triggered rapid hepatocarcinogenesis in mice. gala-PEG-DSPE
66  2020 Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. anti-PD-1, ICI
67  2020 Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. CER, FNH, LLCR, MRI
68  2020 Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. dnSrebp2, FA, FASN, HMG-CoA, SREBP2
69  2020 Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421. circRNA
70  2020 Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. circRNAs, FGFR1
71  2020 CircularRNA as novel biomarkers in liver diseases. circRNA, miRNA, NAFLD, NASH
72  2020 Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis. CSCs, EPCs, HSCs, OS
73  2020 Circulating levels of growth differentiation factor 15 and sex hormones in male patients with HBV-associated hepatocellular carcinoma. BCLC-C, CHB, FT, GDF15, HBV-related LC, TT
74  2020 Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis. ---
75  2020 Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning. AUC
76  2020 Classification and Segmentation of Hyperspectral Data of Hepatocellular Carcinoma Samples Using 1-D Convolutional Neural Network. ---
77  2020 Clathrin switches transforming growth factor-beta role to pro-tumorigenic in liver cancer. CLTC, CLTC, EGFR, TGF-beta
78  2020 Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma. apoB, ARID1A, BCLC, CTNNB1, SF3B1, TERT, TP53
79  2020 Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin. cHCC, MaS, MiS
80  2020 Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. ---
81  2020 Collaborative assembly of doxorubicin and galactosyl diblock glycopolymers for targeted drug delivery of hepatocellular carcinoma. ASGPR, DOX, RAFT, TBAOH
82  2020 Combined hepatocellular-cholangiocarcinoma in a cow. CC, CK
83  2020 Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B. CTP, HBV, OS, PSM
84  2020 Comparison of different kinetic models for dynamic 18F-FDG PET/CT imaging of hepatocellular carcinoma with various, also dual-blood input function. PET/CT, TACs
85  2020 Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. CDAA, MCD, NASH
86  2020 Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients. TACE
87  2020 Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy. C-index, GPS, LMR, mGPS, NLR, PI, PLR, PNI, PRS, ROC, SII
88  2020 Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma. ASH, NASH
89  2020 Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching. MW, OS, PSM, RF, RFS
90  2020 Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma. CLIP-seq, EIF4A3, EJC
91  2020 Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles. NK
92  2020 Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomy. HBV
93  2020 Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging. HBP, MRI
94  2020 Controlling Nutritional Status (CONUT) score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantation. CONUT, HR, LT, NLR, PLR, SHR
95  2020 Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma. BCLC, cTACE, DEB-TACE
96  2020 Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™). AFP, CI, DSS, OR
97  2020 Corrigendum to "Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling" [Biomed. Pharmacother. 116 (2019) 108749]. ---
98  2020 Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma. JNK, MAPK, NF-kappaB, NLRs, PAMPs, TLRs
99  2020 Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. ---
100  2020 Cutaneous metastasis of hepatocellular carcinoma following liver transplantation. ---